If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

Share Price is delayed by 15 minutes
Get Live Data
2,508.00    64.00 (2.62%)
Bid:
2,498.00
Ask:
2,502.00
Spread: 4.00 (0.16%)
Market Cap: £6.51b
WEIR Live PriceLast checked at - London Stock Exchange

Intraday Weir Group Share Chart

Holding(s) in Company

17 Dec 2007 15:30

Weir Group PLC17 December 2007 TR1: Notifications of Major Interests in Shares 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Weir Group plc, The 2. Reason for notification (yes/no) An acquisition or disposal of voting rights Yes An acquisition or disposal of financial instruments which may result inthe acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify):______________ 3. Full name of person(s) subject to notification obligation: Baillie Gifford & Co 4. Full name of shareholder(s) (ifdifferent from 3): 5. Date of transaction (and date on which the threshold is crossed or reached if different):13 December 2007 6. Date on which issuer notified: 17 December 2007 7. Threshold(s) that is/are crossed or reached: 5% 8: Notified DetailsA: Voting rights attached to sharesClass/type Situation previous Resulting situation after the triggeringof shares to the triggering transaction transactionIf possibleuse ISIN Number Number of Number of Number of voting Percentage ofcode of voting shares rights voting rights shares rights Direct Indirect Direct IndirectOrdinary Below Below 5% 12173278 12173278 5.82 5%ShareGB0009465807 B: Financial InstrumentsResulting situation after the triggering transactionType of Expiration Exercise/ No. of voting rights that may Percentagefinancial date conversion be acquired (if the instrument of votinginstrument period/date exercised/converted) rightsN/A Total (A+B)Number of voting rights Percentage of voting rights 12173278 5.82 9. Chain of controlled undertakings through which the voting rights and /or thefinancial instruments are effectively held, if applicable:In the narrative below, the figures in ( ) indicate the amount of voting rightsand the percentage held by each controlled undertaking where relevant.Baillie Gifford & Co, a discretionary investment manager, is the parentundertaking of an investment management group.Its whollyowned direct subsidiary undertaking Baillie Gifford Overseas Limited(1744712; 0.8%) is also a discretionary investment manager.Its whollyowned direct subsidiary undertaking Baillie Gifford Life Limited(2799483; 1.3%) is a life assurance company which procures discretionaryinvestment management services from Baillie Gifford & Co in respect of its ownaccount shareholdings.Its whollyowned indirect (via Baillie Gifford Life Limited) subsidiaryundertaking Baillie Gifford & Co Limited (198600; 0.1%) is an OEIC AuthorisedCorporate Director and Unit Trust Manager which has delegated its discretionaryinvestment management role to Baillie Gifford & Co. Proxy Voting:10. Name of proxy holder: N/A11. Number of voting rights proxy holder will cease to hold:12. Date on which proxy holder will cease to hold voting rights: 13. Additional information:14 Contact name: Myra McIntyre Scott Russell15. Contact telephone number: 0131 275 2154 0131 275 2106 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20262:45 pmRNSDirector/PDMR Shareholding
15th May 20269:16 amRNSHolding(s) in Company
13th May 20268:47 amRNSHolding(s) in Company
11th May 20269:50 amRNSDirector/PDMR Shareholding
8th May 20261:06 pmRNSDirector/PDMR Shareholding
8th May 20268:23 amRNSHolding(s) in Company
30th Apr 20264:24 pmRNSResult of AGM
30th Apr 20267:01 amRNSCEO Succession Announcement
30th Apr 20267:00 amRNSQ1 Trading Update
21st Apr 20262:20 pmRNSDirector/PDMR Shareholding
21st Apr 20262:16 pmRNSDirector/PDMR Shareholding
21st Apr 20262:14 pmRNSDirector/PDMR Shareholding
15th Apr 20264:17 pmRNSDirector/PDMR Shareholding
14th Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20262:48 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 202610:37 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSDirectorate change
31st Mar 20264:10 pmRNSDirector/PDMR Shareholding
26th Mar 20267:34 amRNSHolding(s) in Company
23rd Mar 202612:06 pmRNS2025 Annual Report and 2026 Annual General Meeting
10th Mar 20269:57 amRNSDirector Declaration
6th Mar 20267:56 amRNSHolding(s) in Company
4th Mar 20262:01 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSWeir completes acquisition of ESEL
2nd Mar 20266:23 pmRNSHolding(s) in Company
16th Feb 20263:53 pmRNSHolding(s) in Company
30th Jan 20262:58 pmRNSHolding(s) in Company
26th Jan 202610:00 amRNS-RWeir receives 'A' score from CDP
14th Jan 20263:26 pmRNS-RWeir and Olayan announce key milestone
15th Dec 20258:36 amRNSDirectorate change
12th Dec 202510:30 amRNSWeir to acquire ESEL
4th Dec 20258:49 amRNSDirector Declaration
3rd Dec 20257:00 amRNSWeir Capital Markets Event
19th Nov 202510:02 amRNSDirector Declaration
11th Nov 20257:00 amRNSWeir completes acquisition of Fast2Mine
5th Nov 202512:20 pmRNSDirector/PDMR Shareholding
5th Nov 20257:00 amRNSQ3 Trading Update
16th Oct 20251:48 pmRNSNotification of Change in Director’s Details
16th Oct 202512:00 pmRNSWeir AUD 400m Bond Pricing
23rd Sep 202512:00 pmRNSWeir to acquire Fast2Mine
22nd Sep 20254:05 pmRNSHolding(s) in Company
22nd Sep 20259:08 amRNSHolding(s) in Company
28th Aug 20255:56 pmRNSDirector/PDMR Shareholding
28th Aug 20255:39 pmRNSWeir completes acquisition of Townley
5th Aug 20253:42 pmRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report
23rd Jul 20257:00 amRNS-RWeir retains CDP A score for climate transparency
30th Jun 202511:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.